S&P 500   3,297.81 (+0.51%)
DOW   27,186.83 (+0.14%)
QQQ   269.89 (+0.89%)
AAPL   109.97 (-0.10%)
MSFT   205.08 (+1.25%)
FB   251.35 (+1.29%)
GOOGL   1,446.16 (+1.12%)
AMZN   3,081.52 (+4.09%)
NVDA   495.93 (-0.95%)
TSLA   430.02 (-4.31%)
BABA   272.96 (-0.31%)
CGC   16.02 (+1.78%)
GE   6.26 (-1.42%)
MU   49.28 (+0.26%)
AMD   76.55 (-1.78%)
T   28.56 (-0.24%)
F   6.80 (-1.02%)
ACB   7.45 (+17.88%)
GILD   63.43 (-1.21%)
NFLX   486.14 (-0.25%)
DIS   126.46 (+0.84%)
BAC   23.88 (-2.41%)
BA   156.01 (-0.22%)
S&P 500   3,297.81 (+0.51%)
DOW   27,186.83 (+0.14%)
QQQ   269.89 (+0.89%)
AAPL   109.97 (-0.10%)
MSFT   205.08 (+1.25%)
FB   251.35 (+1.29%)
GOOGL   1,446.16 (+1.12%)
AMZN   3,081.52 (+4.09%)
NVDA   495.93 (-0.95%)
TSLA   430.02 (-4.31%)
BABA   272.96 (-0.31%)
CGC   16.02 (+1.78%)
GE   6.26 (-1.42%)
MU   49.28 (+0.26%)
AMD   76.55 (-1.78%)
T   28.56 (-0.24%)
F   6.80 (-1.02%)
ACB   7.45 (+17.88%)
GILD   63.43 (-1.21%)
NFLX   486.14 (-0.25%)
DIS   126.46 (+0.84%)
BAC   23.88 (-2.41%)
BA   156.01 (-0.22%)
S&P 500   3,297.81 (+0.51%)
DOW   27,186.83 (+0.14%)
QQQ   269.89 (+0.89%)
AAPL   109.97 (-0.10%)
MSFT   205.08 (+1.25%)
FB   251.35 (+1.29%)
GOOGL   1,446.16 (+1.12%)
AMZN   3,081.52 (+4.09%)
NVDA   495.93 (-0.95%)
TSLA   430.02 (-4.31%)
BABA   272.96 (-0.31%)
CGC   16.02 (+1.78%)
GE   6.26 (-1.42%)
MU   49.28 (+0.26%)
AMD   76.55 (-1.78%)
T   28.56 (-0.24%)
F   6.80 (-1.02%)
ACB   7.45 (+17.88%)
GILD   63.43 (-1.21%)
NFLX   486.14 (-0.25%)
DIS   126.46 (+0.84%)
BAC   23.88 (-2.41%)
BA   156.01 (-0.22%)
S&P 500   3,297.81 (+0.51%)
DOW   27,186.83 (+0.14%)
QQQ   269.89 (+0.89%)
AAPL   109.97 (-0.10%)
MSFT   205.08 (+1.25%)
FB   251.35 (+1.29%)
GOOGL   1,446.16 (+1.12%)
AMZN   3,081.52 (+4.09%)
NVDA   495.93 (-0.95%)
TSLA   430.02 (-4.31%)
BABA   272.96 (-0.31%)
CGC   16.02 (+1.78%)
GE   6.26 (-1.42%)
MU   49.28 (+0.26%)
AMD   76.55 (-1.78%)
T   28.56 (-0.24%)
F   6.80 (-1.02%)
ACB   7.45 (+17.88%)
GILD   63.43 (-1.21%)
NFLX   486.14 (-0.25%)
DIS   126.46 (+0.84%)
BAC   23.88 (-2.41%)
BA   156.01 (-0.22%)
Log in
ASX:RAP

Resapp Health Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range
A$0.17
MA: A$0.17
A$0.17
52-Week Range N/A
Volume932,978 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
ResApp Health Limited develops digital healthcare solutions to assist doctors and allow patients to diagnose and manage respiratory disease. The company delivers mobile software apps in various clinical settings, including telehealth, emergency, urgent care, and primary care. Its technology uses sound to diagnose respiratory diseases, including pneumonia, bronchiolitis, bronchitis, chronic obstructive pulmonary disease, and asthma. The company was formerly known as Narhex Life Sciences Limited. ResApp Health Limited was founded in 2014 and is headquartered in Brisbane, Australia.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.56 out of 5 stars


Industry, Sector and Symbol

Industry Health Information Services
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone61 7 3724 0035

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.02 million
Book ValueA$0.01 per share

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive RAP News and Ratings via Email

Sign-up to receive the latest news and ratings for RAP and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Resapp Health (ASX:RAP) Frequently Asked Questions

Who are some of Resapp Health's key competitors?

Who are Resapp Health's key executives?

Resapp Health's management team includes the following people:
  • Dr. Anthony Keating, CEO, MD & Director
  • Ms. Kay Taylor Ph.D., VP of Strategic Devel. & Operations
  • Dr. Udantha Abeyratne, Chief Scientist & Scientific Advisor
  • Ms. Nicki Farley, Company Sec. (Age 43)
  • Dr. Clas Källander, Founder and Director of R&D of Cavidi AB

What is Resapp Health's stock symbol?

Resapp Health trades on the ASX under the ticker symbol "RAP."

How big of a company is Resapp Health?

Resapp Health has a market capitalization of $0.00 and generates $1.02 million in revenue each year.

What is Resapp Health's official website?

The official website for Resapp Health is www.resapphealth.com.au.

How can I contact Resapp Health?

The company can be reached via phone at 61 7 3724 0035.

This page was last updated on 9/22/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.